Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transt...
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd and British Cardiovascular Society
Subjects
More information
Scope and Contents
Contents
ObjectivesWild-type transthyretin amyloid cardiomyopathy (wtATTR-CM) is a progressive and fatal condition. Although prognosis can be determined at the time of diagnosis according to National Amyloidosis Centre (NAC) transthyretin amyloidosis (ATTR) stage, the clinical course varies substantially between individuals. There are currently no establish...
Alternative Titles
Full title
Change in N-terminal pro-B-type natriuretic peptide at 1 year predicts mortality in wild-type transthyretin amyloid cardiomyopathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8899483
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8899483
Other Identifiers
ISSN
1355-6037
E-ISSN
1468-201X
DOI
10.1136/heartjnl-2021-319063
